SC
Shaunak Chirayu Amin
About Shaunak Chirayu Amin
Data last updated:
Shaunak Chirayu Amin is a Managing Director at Alembic Pharmaceuticals Limited (since 2013), Managing Director at Shreno Limited (since 2016) and Director at Fenix Research Labs Private Limited (since 2008), and holds 2 more current directorships. The companies operate in Pharma, Manufacturing and Packaging. The 4 current companies with reported revenue have a combined latest revenue of ₹7,594 Cr; the largest is Alembic Pharmaceuticals Limited at ₹7,399 Cr (FY 2026). Earlier, Shaunak Chirayu Amin was a Director at The Gujarat Flying Club (2003–2015) and Director at Sierra Investments Private Limited (Tr Co ) (2008–2012) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Alembic Pharmaceuticals Limited L24230GJ2010PLC061123 | Managing Director | 02 May 2013 | 2010 | ₹7,399 Cr (FY 2026) | Active |
 Shreno Limited U26100GJ1944PLC000345 | Managing Director | 11 Aug 2016 | 1944 | ₹183 Cr (FY 2025) | Active |
 Fenix Research Labs Private Limited U24239TG2008PTC059967 | Director | 25 Nov 2008 | 2008 | ₹11.62 Cr (FY 2025) | Active |
 Viramya Packlight Llp AAI-0062 | Partner | 14 Dec 2016 | 2016 | ₹18,170 (FY 2026) | Active |
| India Realty Excellence Fund Ii Llp AAB-6882 | Partner | 07 Apr 2015 | 2013 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| The Gujarat Flying Club U92411GJ1958GAT000912 | Director | 18 Sep 2003 | 1958 | ₹11.88 Cr (FY 2025) | Active |
| Sierra Investments Private Limited (Tr Co ) U70109GJ1988PTC044681 | Director | 16 Jun 2008 | 1988 | ₹27.17 Cr (FY 2017) | Amalgamated |
| Shreno Publications Limited U75302GJ2004PLC044463 | Director | 15 Jul 2004 | 2004 | ₹57.80 Cr (FY 2025) | Active |
 Aavaran Limited U24299GJ1970PLC001809 | Director | 09 Dec 2002 | 1970 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shaunak Chirayu Amin
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shaunak Chirayu Amin
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shaunak Chirayu Amin
Shaunak Chirayu Amin currently holds 5 directorships: Alembic Pharmaceuticals Limited (Managing Director, since 02 May 2013, revenue ₹7,399 Cr (FY 2026)); Shreno Limited (Managing Director, since 11 Aug 2016, revenue ₹183 Cr (FY 2025)); Fenix Research Labs Private Limited (Director, since 25 Nov 2008, revenue ₹11.62 Cr (FY 2025)); Viramya Packlight Llp (Partner, since 14 Dec 2016, revenue ₹18,170 (FY 2026)); India Realty Excellence Fund Ii Llp (Partner, since 07 Apr 2015).
Shaunak Chirayu Amin was first appointed on 09 Dec 2002 as Director at Aavaran Limited. The most recent appointment on record is 14 Dec 2016 at Viramya Packlight Llp.
The 4 current companies of Shaunak Chirayu Amin that report revenue have a combined latest revenue of ₹7,594 Cr: Alembic Pharmaceuticals Limited ₹7,399 Cr (FY 2026); Shreno Limited ₹183 Cr (FY 2025); Fenix Research Labs Private Limited ₹11.62 Cr (FY 2025); Viramya Packlight Llp ₹18,170 (FY 2026).
Shaunak Chirayu Amin held 4 earlier board appointments: The Gujarat Flying Club (Director, 18 Sep 2003 to 08 Sep 2015); Sierra Investments Private Limited (Tr Co ) (Director, 16 Jun 2008 to 05 Dec 2012); Shreno Publications Limited (Director, 15 Jul 2004 to 03 Sep 2019); Aavaran Limited (Director, 09 Dec 2002 to 25 Jul 2008).
The current boards of Shaunak Chirayu Amin's companies include Ashok Kumar Barat (Alembic Pharmaceuticals Limited), Chirayu Ramanbhai Amin (Alembic Pharmaceuticals Limited), Ganesan Krishnan (Alembic Pharmaceuticals Limited), Geeta Amit Goradia (Alembic Pharmaceuticals Limited), Jai Shishir Diwanji (Alembic Pharmaceuticals Limited), Manish Santoshkumar Kejriwal (Alembic Pharmaceuticals Limited), among others.